SCHEMBL34468873

SCHEMBL34468873

CC(C)CCCCCCCC(CCCCCCCN(CCO)CCCCCCCC(CCCCCCCC(C)C)C(=O)O)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 2/20 0.41
▸ KDM4A O75164 1/20 0.41
▸ PHF8 Q9UPP1 1/20 0.41
▸ KDM2A Q9Y2K7 1/20 0.41
▸ FOLH1 Q04609 4/20 0.38
▸ BLM P54132 1/20 0.37
▸ GRIK1 P39086 2/20 0.36
▸ GRIK2 Q13002 2/20 0.36
▸ CHRM1 P11229 1/20 0.35
▸ AKR1A1 P14550 1/20 0.35
▸ CHRM3 P20309 1/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ ADRA1A P35348 1/20 0.35
▸ HRH1 P35367 1/20 0.35
▸ DRD3 P35462 1/20 0.35
▸ SLC6A3 Q01959 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC2 Q92769 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5652783 0.86 LMNA (0.39) KDM4CKDM4APHF8KDM2A
SCHEMBL31365936 0.86 LMNA (0.39) KDM4CKDM4APHF8KDM2A
SCHEMBL15563205 0.86 LMNA (0.39) KDM4CKDM4APHF8KDM2A
SCHEMBL2047008 0.86 LMNA (0.39) KDM4CKDM4APHF8KDM2A
SCHEMBL7759645 0.86 LMNA (0.39) KDM4CKDM4APHF8KDM2A
SCHEMBL31365935 0.86 LMNA (0.39) KDM4CKDM4APHF8KDM2A
SCHEMBL9319584 0.86 LMNA (0.39) KDM4CKDM4APHF8KDM2A
SCHEMBL25423187 0.85 GRIK1 (0.49) KDM4CPHF8GRIK1GRIK2CHRM1
SCHEMBL19032582 0.85 GRIK1 (0.49) KDM4CPHF8GRIK1GRIK2CHRM1
SCHEMBL6239055 0.84 LMNA (0.37) KDM4CKDM4APHF8KDM2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260116845-A1 LIPIDS AND COMPOSITIONS THEREOF KERNAL BIOLOGICS INC (US) 2026-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260116845-A1 LIPIDS AND COMPOSITIONS THEREOF LIPC, LIPA, NPC1L1 KDM4C 2863/4885KDM4A 4386/4885PHF8 3073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback